Scorpius Holdings Management
Management criteria checks 4/4
Scorpius Holdings' CEO is Jeff Wolf, appointed in Aug 2008, has a tenure of 15.75 years. total yearly compensation is $575.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 4.63% of the company’s shares, worth $320.03K. The average tenure of the management team and the board of directors is 4.7 years and 7.3 years respectively.
Key information
Jeff Wolf
Chief executive officer
US$575.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 15.8yrs |
| CEO ownership | 4.6% |
| Management average tenure | 4.7yrs |
| Board average tenure | 7.3yrs |
Recent management updates
Recent updates
Here's Why We're Watching Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation
Dec 28
Here's Why We're Not Too Worried About Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation
Sep 02Heat Biologics names Anthony Manning as chief scientific advisor
May 10Heat Biologics EPS misses by $0.01, misses on revenue
May 05We're Hopeful That Heat Biologics (NASDAQ:HTBX) Will Use Its Cash Wisely
Apr 30Reflecting on Heat Biologics' (NASDAQ:HTBX) Share Price Returns Over The Last Five Years
Mar 07Here's Why We're Not Too Worried About Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation
Jan 13
Heat Biologics signs a licensing agreement; Appoints new CFO
Jan 06Heat Biologics soars 14% on completion of ZVX-60 vaccine cell line for COVID-19
Dec 16Introducing Heat Biologics (NASDAQ:HTBX), The Stock That Zoomed 124% In The Last Year
Nov 20Heat Biologics Provides Update, And Other News: The Good, Bad And Ugly Of Biopharma
Nov 02CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$575k | US$575k | -US$40m |
| Sep 30 2023 | n/a | n/a | -US$53m |
| Jun 30 2023 | n/a | n/a | -US$55m |
| Mar 31 2023 | n/a | n/a | -US$48m |
| Dec 31 2022 | US$3m | US$562k | -US$43m |
| Sep 30 2022 | n/a | n/a | -US$38m |
| Jun 30 2022 | n/a | n/a | -US$36m |
| Mar 31 2022 | n/a | n/a | -US$36m |
| Dec 31 2021 | US$6m | US$540k | -US$35m |
| Sep 30 2021 | n/a | n/a | -US$28m |
| Jun 30 2021 | n/a | n/a | -US$29m |
| Mar 31 2021 | n/a | n/a | -US$27m |
| Dec 31 2020 | US$6m | US$440k | -US$26m |
| Sep 30 2020 | n/a | n/a | -US$23m |
| Jun 30 2020 | n/a | n/a | -US$20m |
| Mar 31 2020 | n/a | n/a | -US$21m |
| Dec 31 2019 | US$3m | US$428k | -US$20m |
| Sep 30 2019 | n/a | n/a | -US$22m |
| Jun 30 2019 | n/a | n/a | -US$19m |
| Mar 31 2019 | n/a | n/a | -US$18m |
| Dec 31 2018 | US$1m | US$417k | -US$16m |
| Sep 30 2018 | n/a | n/a | -US$14m |
| Jun 30 2018 | n/a | n/a | -US$13m |
| Mar 31 2018 | n/a | n/a | -US$12m |
| Dec 31 2017 | US$964k | US$417k | -US$12m |
Compensation vs Market: Jeff's total compensation ($USD575.00K) is about average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.
CEO
Jeff Wolf (60 yo)
15.8yrs
Tenure
US$575,000
Compensation
Mr. Jeffrey Alan Wolf, also known as Jeff, J.D. founded Scorpius Holdings, Inc. (formerly known as NightHawk Biosciences, Inc.) (formerly known as Heat Biologics, Inc.) in August 2008 and has been its Chai...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 15.8yrs | US$575.00k | 4.63% $ 320.0k | |
| CFO & Secretary | 4.7yrs | US$375.00k | 0.018% $ 1.3k | |
| Chief Medical Advisor and Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Chief Medical Advisor | 7.1yrs | no data | no data | |
| Site Head of Quality | less than a year | no data | no data | |
| President & COO of Scorpius BioManufacturing | less than a year | no data | no data |
4.7yrs
Average Tenure
Experienced Management: SCPX's management team is considered experienced (4.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 15.8yrs | US$575.00k | 4.63% $ 320.0k | |
| Chief Medical Advisor and Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Independent Lead Director | 8.1yrs | US$301.00k | 0.66% $ 45.7k | |
| Independent Director | 14.5yrs | US$81.50k | 0.00020% $ 13.8 | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Scientific Advisory Board Member | 6.2yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Chairman of BioThreat Advisory Board | 2yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 6.6yrs | no data | no data | |
| Independent Director | 13.5yrs | US$92.50k | 0.00040% $ 27.7 | |
| Member of Scientific Advisory Board | 6.6yrs | no data | no data |
7.3yrs
Average Tenure
69yo
Average Age
Experienced Board: SCPX's board of directors are considered experienced (7.3 years average tenure).